Yahoo Web Search

Search results

    • Q1 2024 Arcutis Biotherapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 17 hours ago

      Moving to slide 10. As a reminder, the ZORYVE was approved for Seb Derm patients in mid-December 2023, with a commercial launch in late January 2024. As read, seborrheic launch ...

    • Q1 2024 PAVmed Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      Before proceeding, I'd like to thank our long-term shareholders for your ongoing support and commitment we continue to leave no stone...strengthened the EsoGuard clinical ...